

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 6.74215397 |
| 2 | locomotory exploration behavior (GO:0035641) | 6.58381123 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 6.34411703 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.84845552 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.74525025 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.12724903 |
| 7 | cellular glucuronidation (GO:0052695) | 5.12339506 |
| 8 | lipoprotein transport (GO:0042953) | 5.02311391 |
| 9 | vocalization behavior (GO:0071625) | 5.01679525 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.00210894 |
| 11 | exploration behavior (GO:0035640) | 4.92626171 |
| 12 | exogenous drug catabolic process (GO:0042738) | 4.90626869 |
| 13 | glucuronate metabolic process (GO:0019585) | 4.87637246 |
| 14 | uronic acid metabolic process (GO:0006063) | 4.87637246 |
| 15 | drug catabolic process (GO:0042737) | 4.80863692 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.78404127 |
| 17 | drug metabolic process (GO:0017144) | 4.72513499 |
| 18 | urea metabolic process (GO:0019627) | 4.66349400 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.65129982 |
| 20 | regulation of bile acid biosynthetic process (GO:0070857) | 4.62494020 |
| 21 | intestinal absorption (GO:0050892) | 4.52366318 |
| 22 | urea cycle (GO:0000050) | 4.44443351 |
| 23 | hormone catabolic process (GO:0042447) | 4.35094916 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 4.34463721 |
| 25 | glutamate secretion (GO:0014047) | 4.29184381 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.27523556 |
| 27 | regulation of guanylate cyclase activity (GO:0031282) | 4.26810090 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.25976956 |
| 29 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.24595015 |
| 30 | bile acid and bile salt transport (GO:0015721) | 4.24111201 |
| 31 | omega-hydroxylase P450 pathway (GO:0097267) | 4.21012554 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 4.20137802 |
| 33 | protein localization to synapse (GO:0035418) | 4.17008205 |
| 34 | NADH metabolic process (GO:0006734) | 4.16240931 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.14035188 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.11548171 |
| 37 | synaptic vesicle maturation (GO:0016188) | 4.08080301 |
| 38 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.05382587 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.99992246 |
| 40 | presynaptic membrane assembly (GO:0097105) | 3.98718518 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 3.98251073 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.93299686 |
| 43 | neuron-neuron synaptic transmission (GO:0007270) | 3.91310919 |
| 44 | neuron recognition (GO:0008038) | 3.91287283 |
| 45 | long-term synaptic potentiation (GO:0060291) | 3.90715585 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87810002 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.86570919 |
| 48 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.78770857 |
| 49 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.77533537 |
| 50 | positive regulation of membrane potential (GO:0045838) | 3.73014949 |
| 51 | flavonoid metabolic process (GO:0009812) | 3.71894179 |
| 52 | regulation of synaptic vesicle transport (GO:1902803) | 3.70076100 |
| 53 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.70030758 |
| 54 | bile acid metabolic process (GO:0008206) | 3.69092818 |
| 55 | renal system process involved in regulation of blood volume (GO:0001977) | 3.68810400 |
| 56 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.66744063 |
| 57 | endocrine process (GO:0050886) | 3.66744063 |
| 58 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.66744063 |
| 59 | postsynaptic membrane organization (GO:0001941) | 3.65499896 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.63834703 |
| 61 | neurotransmitter secretion (GO:0007269) | 3.60929073 |
| 62 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.60105234 |
| 63 | presynaptic membrane organization (GO:0097090) | 3.57374966 |
| 64 | axonal fasciculation (GO:0007413) | 3.56179505 |
| 65 | alkaloid metabolic process (GO:0009820) | 3.51214399 |
| 66 | startle response (GO:0001964) | 3.47865212 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47636335 |
| 68 | long-term memory (GO:0007616) | 3.45633829 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.43981938 |
| 70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.41270338 |
| 71 | phospholipid efflux (GO:0033700) | 3.38036032 |
| 72 | response to histamine (GO:0034776) | 3.37738396 |
| 73 | drug transmembrane transport (GO:0006855) | 3.37701134 |
| 74 | neuronal ion channel clustering (GO:0045161) | 3.36951515 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.35248447 |
| 76 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.35114263 |
| 77 | regulation of synaptic plasticity (GO:0048167) | 3.31126622 |
| 78 | adhesion of symbiont to host cell (GO:0044650) | 3.31120474 |
| 79 | virion attachment to host cell (GO:0019062) | 3.31120474 |
| 80 | fructose metabolic process (GO:0006000) | 3.30818473 |
| 81 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28296368 |
| 82 | neurotransmitter transport (GO:0006836) | 3.26382368 |
| 83 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.25371374 |
| 84 | regulation of systemic arterial blood pressure (GO:0003073) | 3.25035081 |
| 85 | cellular potassium ion homeostasis (GO:0030007) | 3.23006485 |
| 86 | nucleobase catabolic process (GO:0046113) | 3.22019401 |
| 87 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21336653 |
| 88 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.21154671 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 3.19831792 |
| 90 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.16292467 |
| 91 | regulation of synapse structural plasticity (GO:0051823) | 3.11851762 |
| 92 | positive regulation of synapse maturation (GO:0090129) | 3.09873392 |
| 93 | dendrite morphogenesis (GO:0048813) | 3.08297717 |
| 94 | drug transport (GO:0015893) | 3.08293639 |
| 95 | * L-amino acid import (GO:0043092) | 3.06789179 |
| 96 | layer formation in cerebral cortex (GO:0021819) | 3.03267288 |
| 97 | neuromuscular process controlling balance (GO:0050885) | 3.02792556 |
| 98 | * amino acid import (GO:0043090) | 3.00550405 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.00186872 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.99076701 |
| 101 | regulation of cholesterol esterification (GO:0010872) | 2.98118648 |
| 102 | lipoprotein metabolic process (GO:0042157) | 2.97878331 |
| 103 | behavioral defense response (GO:0002209) | 2.97598919 |
| 104 | behavioral fear response (GO:0001662) | 2.97598919 |
| 105 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.96017872 |
| 106 | ethanol oxidation (GO:0006069) | 2.95866481 |
| 107 | peptide hormone processing (GO:0016486) | 2.94790792 |
| 108 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.94672059 |
| 109 | learning (GO:0007612) | 2.94420114 |
| 110 | sodium ion homeostasis (GO:0055078) | 2.93836171 |
| 111 | cellular response to nitric oxide (GO:0071732) | 2.93808137 |
| 112 | midgut development (GO:0007494) | 2.90338133 |
| 113 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.89293581 |
| 114 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.89129042 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.89020016 |
| 116 | phosphate ion transmembrane transport (GO:0035435) | 2.87271875 |
| 117 | positive regulation of pseudopodium assembly (GO:0031274) | 2.87097550 |
| 118 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.86928587 |
| 119 | membrane hyperpolarization (GO:0060081) | 2.86583183 |
| 120 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.86099056 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.86099056 |
| 122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84957852 |
| 123 | regulation of cGMP biosynthetic process (GO:0030826) | 2.84917948 |
| 124 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84809437 |
| 125 | adhesion of symbiont to host (GO:0044406) | 2.84002206 |
| 126 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83717612 |
| 127 | heme transport (GO:0015886) | 2.83114617 |
| 128 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.81319994 |
| 129 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.81319994 |
| 130 | cerebellar granule cell differentiation (GO:0021707) | 2.80592962 |
| 131 | neuron remodeling (GO:0016322) | 2.80476453 |
| 132 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.79933276 |
| 133 | regulation of neuron projection regeneration (GO:0070570) | 2.79817778 |
| 134 | regulation of axon regeneration (GO:0048679) | 2.79817778 |
| 135 | synapse assembly (GO:0007416) | 2.79806836 |
| 136 | protein-lipid complex assembly (GO:0065005) | 2.79620675 |
| 137 | regulation of neurotransmitter secretion (GO:0046928) | 2.79273270 |
| 138 | dendritic spine organization (GO:0097061) | 2.78760159 |
| 139 | synapse organization (GO:0050808) | 2.78134541 |
| 140 | positive regulation of synapse assembly (GO:0051965) | 2.77580022 |
| 141 | positive regulation of synaptic transmission (GO:0050806) | 2.76099787 |
| 142 | negative regulation of axon extension (GO:0030517) | 2.75786819 |
| 143 | cellular response to ammonium ion (GO:0071242) | 2.75140282 |
| 144 | high-density lipoprotein particle remodeling (GO:0034375) | 2.74996714 |
| 145 | fear response (GO:0042596) | 2.74695681 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 2.74511497 |
| 147 | regulation of dendritic spine development (GO:0060998) | 2.73959890 |
| 148 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.73287339 |
| 149 | activated T cell proliferation (GO:0050798) | 2.72089309 |
| 150 | proline transport (GO:0015824) | 2.72071314 |
| 151 | long term synaptic depression (GO:0060292) | 2.71386924 |
| 152 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.70923651 |
| 153 | neuromuscular process controlling posture (GO:0050884) | 2.70109665 |
| 154 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.69773234 |
| 155 | cholesterol efflux (GO:0033344) | 2.69570066 |
| 156 | regulation of protein activation cascade (GO:2000257) | 2.69275745 |
| 157 | neuromuscular process (GO:0050905) | 2.69020702 |
| 158 | transferrin transport (GO:0033572) | 2.68929648 |
| 159 | regulation of synapse maturation (GO:0090128) | 2.67515501 |
| 160 | sodium ion export (GO:0071436) | 2.67455611 |
| 161 | phenylpropanoid metabolic process (GO:0009698) | 2.66355297 |
| 162 | drinking behavior (GO:0042756) | 2.66153453 |
| 163 | auditory behavior (GO:0031223) | 2.66115671 |
| 164 | diacylglycerol metabolic process (GO:0046339) | 2.65795666 |
| 165 | regulation of synaptic transmission (GO:0050804) | 2.65067956 |
| 166 | digestion (GO:0007586) | 2.64156472 |
| 167 | regulation of female receptivity (GO:0045924) | 2.63466159 |
| 168 | regulation of vesicle fusion (GO:0031338) | 2.62980899 |
| 169 | innervation (GO:0060384) | 2.61332846 |
| 170 | cellular response to reactive nitrogen species (GO:1902170) | 2.60468573 |
| 171 | phosphate ion transport (GO:0006817) | 2.60398027 |
| 172 | negative regulation of sterol transport (GO:0032372) | 2.58640972 |
| 173 | negative regulation of cholesterol transport (GO:0032375) | 2.58640972 |
| 174 | actin filament depolymerization (GO:0030042) | 2.56502355 |
| 175 | regulation of cholesterol homeostasis (GO:2000188) | 2.54590905 |
| 176 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.53488638 |
| 177 | protein-lipid complex remodeling (GO:0034368) | 2.51446521 |
| 178 | macromolecular complex remodeling (GO:0034367) | 2.51446521 |
| 179 | plasma lipoprotein particle remodeling (GO:0034369) | 2.51446521 |
| 180 | regulation of complement activation (GO:0030449) | 2.51359086 |
| 181 | arginine metabolic process (GO:0006525) | 2.48608672 |
| 182 | regulation of pseudopodium assembly (GO:0031272) | 2.48316575 |
| 183 | reverse cholesterol transport (GO:0043691) | 2.47847510 |
| 184 | fat-soluble vitamin metabolic process (GO:0006775) | 2.47101177 |
| 185 | homocysteine metabolic process (GO:0050667) | 2.46219573 |
| 186 | neurotransmitter biosynthetic process (GO:0042136) | 2.46170915 |
| 187 | iron coordination entity transport (GO:1901678) | 2.43760699 |
| 188 | glycosylceramide metabolic process (GO:0006677) | 2.43726236 |
| 189 | oxidative demethylation (GO:0070989) | 2.42836899 |
| 190 | coenzyme catabolic process (GO:0009109) | 2.40145358 |
| 191 | complement activation, alternative pathway (GO:0006957) | 2.39852635 |
| 192 | vitamin transport (GO:0051180) | 2.39037767 |
| 193 | vitamin biosynthetic process (GO:0009110) | 2.38895809 |
| 194 | cholesterol homeostasis (GO:0042632) | 2.37393379 |
| 195 | cGMP biosynthetic process (GO:0006182) | 2.36059569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.58635805 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82296810 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.57335806 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.19363370 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.09952910 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07608362 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04219955 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94825263 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59669622 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55210545 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55210545 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47591124 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45700557 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39876546 |
| 15 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.37456950 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37327709 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34525710 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31809495 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31169420 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11880845 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11756799 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11321189 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.09410325 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09206897 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07300621 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04510569 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00916449 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00385811 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99892594 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94339322 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.93837998 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89418836 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85117495 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.82793488 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75884907 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72631608 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72308911 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.69586534 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66319707 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65282785 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63258358 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61982536 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61920403 |
| 44 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61519992 |
| 45 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57675069 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57616462 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57197964 |
| 48 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.55997965 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55508883 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54035207 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51442772 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48112602 |
| 53 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47046252 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47016891 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45330192 |
| 56 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44416984 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44184503 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41962459 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.41811118 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40853677 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40607075 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40094488 |
| 63 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38947026 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38380487 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.37975569 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35473641 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34210548 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33661745 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32549810 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31990855 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31103442 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27736823 |
| 73 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25807843 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25646309 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24128470 |
| 76 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23985785 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23335352 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22896263 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21882603 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20907383 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20335729 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19327832 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18778706 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18661027 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18641772 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18346576 |
| 87 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18133621 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17748576 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17486555 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17485644 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17084956 |
| 92 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16774337 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16416485 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16197868 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13919429 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13919429 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12621096 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12471385 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11324137 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10026390 |
| 101 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09949032 |
| 102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09925072 |
| 103 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09758212 |
| 104 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09434571 |
| 105 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08904013 |
| 106 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06525072 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06385549 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05647597 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05186274 |
| 110 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05156672 |
| 111 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04282709 |
| 112 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04243547 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02821542 |
| 114 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01976608 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01154859 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00918184 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00918184 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00549478 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00242132 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00187400 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00004070 |
| 122 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99684302 |
| 123 | * AR_19668381_ChIP-Seq_PC3_Human | 0.97659448 |
| 124 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.97209382 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96981943 |
| 126 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96655137 |
| 127 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95165809 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95155802 |
| 129 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94680098 |
| 130 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93376497 |
| 131 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92626916 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92607633 |
| 133 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91165079 |
| 134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90807143 |
| 135 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90358118 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90317991 |
| 137 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89992782 |
| 138 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89497793 |
| 139 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88640572 |
| 140 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88439594 |
| 141 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86572803 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86462673 |
| 143 | JUN_21703547_ChIP-Seq_K562_Human | 0.86422237 |
| 144 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85975619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.64532759 |
| 2 | MP0003880_abnormal_central_pattern | 5.25524718 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.00529852 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.92541018 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.05145904 |
| 6 | MP0005365_abnormal_bile_salt | 4.03220672 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.79383883 |
| 8 | MP0009745_abnormal_behavioral_response | 3.37548839 |
| 9 | MP0004270_analgesia | 3.36204587 |
| 10 | MP0003183_abnormal_peptide_metabolism | 3.34195683 |
| 11 | MP0002064_seizures | 3.21219169 |
| 12 | MP0002063_abnormal_learning/memory/cond | 3.07016089 |
| 13 | MP0009046_muscle_twitch | 3.01930318 |
| 14 | MP0009840_abnormal_foam_cell | 2.90687799 |
| 15 | MP0001486_abnormal_startle_reflex | 2.82539796 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.69565783 |
| 17 | MP0003868_abnormal_feces_composition | 2.57267080 |
| 18 | MP0002822_catalepsy | 2.56832709 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.54089551 |
| 20 | * MP0002272_abnormal_nervous_system | 2.50295996 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.49671434 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.31143860 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.28113369 |
| 24 | MP0004885_abnormal_endolymph | 2.26775537 |
| 25 | MP0003252_abnormal_bile_duct | 2.19295778 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.14919770 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 2.11940251 |
| 28 | MP0003329_amyloid_beta_deposits | 2.11699486 |
| 29 | MP0002736_abnormal_nociception_after | 2.11155684 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10107725 |
| 31 | MP0000778_abnormal_nervous_system | 2.07402534 |
| 32 | MP0002735_abnormal_chemical_nociception | 2.00603949 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.97184610 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.95424101 |
| 35 | MP0004043_abnormal_pH_regulation | 1.81428571 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.78481704 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.72377516 |
| 38 | MP0001970_abnormal_pain_threshold | 1.69283459 |
| 39 | MP0004742_abnormal_vestibular_system | 1.68901966 |
| 40 | MP0001529_abnormal_vocalization | 1.65813607 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.63841231 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.62962224 |
| 43 | MP0005670_abnormal_white_adipose | 1.62279676 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.62017736 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.60467515 |
| 46 | MP0004272_abnormal_basement_membrane | 1.59589743 |
| 47 | MP0001905_abnormal_dopamine_level | 1.55355330 |
| 48 | MP0003879_abnormal_hair_cell | 1.51249618 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.49117411 |
| 50 | MP0001984_abnormal_olfaction | 1.49077347 |
| 51 | MP0003690_abnormal_glial_cell | 1.48850146 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.46547798 |
| 53 | MP0004924_abnormal_behavior | 1.45931645 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.45931645 |
| 55 | MP0002184_abnormal_innervation | 1.45341646 |
| 56 | MP0000920_abnormal_myelination | 1.43289819 |
| 57 | MP0008569_lethality_at_weaning | 1.42646047 |
| 58 | * MP0002066_abnormal_motor_capabilities/c | 1.39941169 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.39400540 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.39118248 |
| 61 | MP0001188_hyperpigmentation | 1.35144728 |
| 62 | * MP0002882_abnormal_neuron_morphology | 1.33100260 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.32979862 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.32568450 |
| 65 | MP0005646_abnormal_pituitary_gland | 1.32404040 |
| 66 | MP0004858_abnormal_nervous_system | 1.31915958 |
| 67 | MP0009379_abnormal_foot_pigmentation | 1.30139139 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.26907494 |
| 69 | MP0005171_absent_coat_pigmentation | 1.26350312 |
| 70 | * MP0009643_abnormal_urine_homeostasis | 1.25964481 |
| 71 | MP0000955_abnormal_spinal_cord | 1.25338670 |
| 72 | MP0004142_abnormal_muscle_tone | 1.24253931 |
| 73 | MP0005409_darkened_coat_color | 1.23937753 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.22670598 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 1.22102852 |
| 76 | MP0003878_abnormal_ear_physiology | 1.22102852 |
| 77 | MP0001765_abnormal_ion_homeostasis | 1.20787341 |
| 78 | MP0004811_abnormal_neuron_physiology | 1.16135482 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 1.15789990 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.14916988 |
| 81 | MP0001177_atelectasis | 1.12130109 |
| 82 | MP0003633_abnormal_nervous_system | 1.11937209 |
| 83 | MP0003631_nervous_system_phenotype | 1.09220244 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 1.07806429 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 1.06984044 |
| 86 | MP0002229_neurodegeneration | 1.04382876 |
| 87 | MP0003634_abnormal_glial_cell | 1.02962749 |
| 88 | MP0002152_abnormal_brain_morphology | 1.02062237 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 1.00972451 |
| 90 | MP0001958_emphysema | 1.00606077 |
| 91 | MP0003632_abnormal_nervous_system | 0.99494115 |
| 92 | MP0002909_abnormal_adrenal_gland | 0.99058601 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.96028009 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.92588583 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.91148204 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.89712257 |
| 97 | MP0001764_abnormal_homeostasis | 0.89261182 |
| 98 | MP0003136_yellow_coat_color | 0.88975955 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.88892621 |
| 100 | * MP0002752_abnormal_somatic_nervous | 0.87998641 |
| 101 | MP0003941_abnormal_skin_development | 0.87014762 |
| 102 | MP0004484_altered_response_of | 0.86528569 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.85343176 |
| 104 | MP0010155_abnormal_intestine_physiology | 0.83488894 |
| 105 | MP0000604_amyloidosis | 0.81552656 |
| 106 | MP0005535_abnormal_body_temperature | 0.81089155 |
| 107 | MP0005332_abnormal_amino_acid | 0.80585212 |
| 108 | MP0003938_abnormal_ear_development | 0.80522848 |
| 109 | MP0003787_abnormal_imprinting | 0.80320467 |
| 110 | MP0004147_increased_porphyrin_level | 0.80099922 |
| 111 | MP0005166_decreased_susceptibility_to | 0.79224944 |
| 112 | MP0001661_extended_life_span | 0.78235354 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.77889158 |
| 114 | MP0005275_abnormal_skin_tensile | 0.75425984 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75286991 |
| 116 | MP0000026_abnormal_inner_ear | 0.74912342 |
| 117 | MP0008872_abnormal_physiological_respon | 0.74874913 |
| 118 | MP0008874_decreased_physiological_sensi | 0.73625410 |
| 119 | MP0002090_abnormal_vision | 0.73513263 |
| 120 | MP0008004_abnormal_stomach_pH | 0.72936948 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.72269506 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.71203847 |
| 123 | MP0002971_abnormal_brown_adipose | 0.70844975 |
| 124 | MP0005257_abnormal_intraocular_pressure | 0.70737473 |
| 125 | MP0005448_abnormal_energy_balance | 0.70672824 |
| 126 | MP0004215_abnormal_myocardial_fiber | 0.70473735 |
| 127 | MP0004085_abnormal_heartbeat | 0.68287670 |
| 128 | MP0000609_abnormal_liver_physiology | 0.67945145 |
| 129 | MP0003283_abnormal_digestive_organ | 0.67779263 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.67528333 |
| 131 | MP0000751_myopathy | 0.66576927 |
| 132 | MP0003172_abnormal_lysosome_physiology | 0.65089864 |
| 133 | MP0001756_abnormal_urination | 0.64961776 |
| 134 | MP0005360_urolithiasis | 0.64673108 |
| 135 | MP0009384_cardiac_valve_regurgitation | 0.64033475 |
| 136 | MP0000462_abnormal_digestive_system | 0.63639643 |
| 137 | MP0001664_abnormal_digestion | 0.63631411 |
| 138 | MP0003091_abnormal_cell_migration | 0.62969817 |
| 139 | MP0003705_abnormal_hypodermis_morpholog | 0.62814747 |
| 140 | MP0000537_abnormal_urethra_morphology | 0.62689720 |
| 141 | MP0000534_abnormal_ureter_morphology | 0.60956220 |
| 142 | MP0005084_abnormal_gallbladder_morpholo | 0.57974791 |
| 143 | MP0003195_calcinosis | 0.57135902 |
| 144 | MP0003122_maternal_imprinting | 0.56760893 |
| 145 | MP0010368_abnormal_lymphatic_system | 0.56586463 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.55172845 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.54987027 |
| 148 | MP0000566_synostosis | 0.54658784 |
| 149 | MP0000747_muscle_weakness | 0.54405506 |
| 150 | MP0003718_maternal_effect | 0.51833354 |
| 151 | MP0002254_reproductive_system_inflammat | 0.50655881 |
| 152 | MP0009642_abnormal_blood_homeostasis | 0.48480744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.40614226 |
| 2 | Focal motor seizures (HP:0011153) | 7.34426290 |
| 3 | Hydroxyprolinuria (HP:0003080) | 5.98485169 |
| 4 | Abnormality of proline metabolism (HP:0010907) | 5.98485169 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.81287009 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.31629407 |
| 7 | Myokymia (HP:0002411) | 5.07535448 |
| 8 | Focal seizures (HP:0007359) | 4.97659664 |
| 9 | Increased circulating renin level (HP:0000848) | 4.89418890 |
| 10 | Atonic seizures (HP:0010819) | 4.88074278 |
| 11 | Malnutrition (HP:0004395) | 4.67735418 |
| 12 | Fat malabsorption (HP:0002630) | 4.45884233 |
| 13 | Visual hallucinations (HP:0002367) | 4.28327642 |
| 14 | Metabolic alkalosis (HP:0200114) | 4.20604722 |
| 15 | Epileptic encephalopathy (HP:0200134) | 3.97637020 |
| 16 | Hypomagnesemia (HP:0002917) | 3.93508144 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.92210853 |
| 18 | Febrile seizures (HP:0002373) | 3.83680918 |
| 19 | Absence seizures (HP:0002121) | 3.79663669 |
| 20 | Complement deficiency (HP:0004431) | 3.79094657 |
| 21 | Dialeptic seizures (HP:0011146) | 3.78054010 |
| 22 | Hyperventilation (HP:0002883) | 3.76911151 |
| 23 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.68300590 |
| 24 | Hypokalemic alkalosis (HP:0001949) | 3.60905285 |
| 25 | Abnormality of magnesium homeostasis (HP:0004921) | 3.42613207 |
| 26 | Abnormality of vitamin metabolism (HP:0100508) | 3.41927820 |
| 27 | Gout (HP:0001997) | 3.41363430 |
| 28 | Abnormal eating behavior (HP:0100738) | 3.39577753 |
| 29 | Hyperactive renin-angiotensin system (HP:0000841) | 3.39209090 |
| 30 | Abnormality of vitamin B metabolism (HP:0004340) | 3.37043462 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 3.34815786 |
| 32 | Broad-based gait (HP:0002136) | 3.29326139 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.28773859 |
| 34 | Abnormality of complement system (HP:0005339) | 3.27033545 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.25527278 |
| 36 | Progressive cerebellar ataxia (HP:0002073) | 3.25401568 |
| 37 | Acanthocytosis (HP:0001927) | 3.22756879 |
| 38 | Generalized tonic-clonic seizures (HP:0002069) | 3.17690800 |
| 39 | Widely patent fontanelles and sutures (HP:0004492) | 3.12900797 |
| 40 | Fetal akinesia sequence (HP:0001989) | 3.08440662 |
| 41 | Mutism (HP:0002300) | 3.07995631 |
| 42 | Proximal tubulopathy (HP:0000114) | 2.98330551 |
| 43 | Polyphagia (HP:0002591) | 2.96358672 |
| 44 | Polyuria (HP:0000103) | 2.95681110 |
| 45 | Steatorrhea (HP:0002570) | 2.90128231 |
| 46 | Xanthomatosis (HP:0000991) | 2.89850697 |
| 47 | Nephrolithiasis (HP:0000787) | 2.86612384 |
| 48 | Focal segmental glomerulosclerosis (HP:0000097) | 2.84697556 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.84172367 |
| 50 | Hyperaldosteronism (HP:0000859) | 2.83227709 |
| 51 | Ileus (HP:0002595) | 2.79534418 |
| 52 | Abnormal urine output (HP:0012590) | 2.77377275 |
| 53 | Chronic diarrhea (HP:0002028) | 2.77055877 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.74766433 |
| 55 | Glycosuria (HP:0003076) | 2.74766433 |
| 56 | Dysmetria (HP:0001310) | 2.72332028 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71451938 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.71451938 |
| 59 | Pigmentary retinal degeneration (HP:0001146) | 2.70268058 |
| 60 | Abnormality of renin-angiotensin system (HP:0000847) | 2.70159426 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.68791258 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.66296181 |
| 63 | Action tremor (HP:0002345) | 2.64731122 |
| 64 | Polydipsia (HP:0001959) | 2.60196948 |
| 65 | Abnormal drinking behavior (HP:0030082) | 2.60196948 |
| 66 | Abnormality of renal excretion (HP:0011036) | 2.59699152 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.59055686 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.57801900 |
| 69 | Excessive salivation (HP:0003781) | 2.56238425 |
| 70 | Drooling (HP:0002307) | 2.56238425 |
| 71 | Generalized myoclonic seizures (HP:0002123) | 2.56014350 |
| 72 | Intention tremor (HP:0002080) | 2.47582654 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.46216502 |
| 74 | Abdominal distention (HP:0003270) | 2.45908900 |
| 75 | Tetany (HP:0001281) | 2.45050425 |
| 76 | Abnormality of chloride homeostasis (HP:0011422) | 2.44946779 |
| 77 | Thin bony cortex (HP:0002753) | 2.44775783 |
| 78 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.39200709 |
| 79 | Epidermoid cyst (HP:0200040) | 2.38517831 |
| 80 | Impaired social interactions (HP:0000735) | 2.36874539 |
| 81 | Abnormal social behavior (HP:0012433) | 2.36874539 |
| 82 | Facial shape deformation (HP:0011334) | 2.36121524 |
| 83 | Potter facies (HP:0002009) | 2.36121524 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.36052636 |
| 85 | Poor eye contact (HP:0000817) | 2.35156082 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 2.34327975 |
| 87 | Confusion (HP:0001289) | 2.33578359 |
| 88 | Scanning speech (HP:0002168) | 2.33210780 |
| 89 | Deep venous thrombosis (HP:0002625) | 2.32126751 |
| 90 | Renal salt wasting (HP:0000127) | 2.32048858 |
| 91 | Amblyopia (HP:0000646) | 2.31525756 |
| 92 | Anxiety (HP:0000739) | 2.29352131 |
| 93 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.27543969 |
| 94 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.27543969 |
| 95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.27519663 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.25834401 |
| 97 | Inability to walk (HP:0002540) | 2.25152961 |
| 98 | Wide cranial sutures (HP:0010537) | 2.25146406 |
| 99 | Peripheral hypomyelination (HP:0007182) | 2.24972737 |
| 100 | Diplopia (HP:0000651) | 2.24898932 |
| 101 | Abnormality of binocular vision (HP:0011514) | 2.24898932 |
| 102 | Ankle clonus (HP:0011448) | 2.23782109 |
| 103 | Insidious onset (HP:0003587) | 2.21927356 |
| 104 | Termporal pattern (HP:0011008) | 2.21927356 |
| 105 | Postural instability (HP:0002172) | 2.21301973 |
| 106 | Glomerulonephritis (HP:0000099) | 2.18652488 |
| 107 | Nephritis (HP:0000123) | 2.16781385 |
| 108 | Hyperammonemia (HP:0001987) | 2.16753989 |
| 109 | Protrusio acetabuli (HP:0003179) | 2.15213151 |
| 110 | Truncal ataxia (HP:0002078) | 2.14589870 |
| 111 | Vascular calcification (HP:0004934) | 2.13582761 |
| 112 | Progressive inability to walk (HP:0002505) | 2.12992793 |
| 113 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12665164 |
| 114 | Delusions (HP:0000746) | 2.12007043 |
| 115 | Limb dystonia (HP:0002451) | 2.11572401 |
| 116 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.11222723 |
| 117 | Hemiparesis (HP:0001269) | 2.10899959 |
| 118 | Absent speech (HP:0001344) | 2.10448143 |
| 119 | Glomerulosclerosis (HP:0000096) | 2.07556035 |
| 120 | Hypophosphatemia (HP:0002148) | 2.06660968 |
| 121 | Ventricular fibrillation (HP:0001663) | 2.06578832 |
| 122 | Spastic gait (HP:0002064) | 2.05312720 |
| 123 | Increased purine levels (HP:0004368) | 2.05030682 |
| 124 | Hyperuricemia (HP:0002149) | 2.05030682 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 2.04872792 |
| 126 | Depression (HP:0000716) | 2.03570164 |
| 127 | Stereotypic behavior (HP:0000733) | 2.02673236 |
| 128 | Osteomalacia (HP:0002749) | 2.01450071 |
| 129 | Epileptiform EEG discharges (HP:0011182) | 2.00559419 |
| 130 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00426348 |
| 131 | Hyperlipoproteinemia (HP:0010980) | 2.00248846 |
| 132 | Akinesia (HP:0002304) | 1.97093497 |
| 133 | Enlarged epiphyses (HP:0010580) | 1.97030385 |
| 134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96432656 |
| 135 | Megaloblastic anemia (HP:0001889) | 1.96249370 |
| 136 | Premature rupture of membranes (HP:0001788) | 1.95721659 |
| 137 | Absent hand (HP:0004050) | 1.94429675 |
| 138 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93863002 |
| 139 | Flat acetabular roof (HP:0003180) | 1.93650236 |
| 140 | Hypoplastic nipples (HP:0002557) | 1.93472800 |
| 141 | Alkalosis (HP:0001948) | 1.93263891 |
| 142 | Hyperphosphaturia (HP:0003109) | 1.92893066 |
| 143 | Blue irides (HP:0000635) | 1.92411305 |
| 144 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.89106781 |
| 145 | Decreased circulating renin level (HP:0003351) | 1.88144375 |
| 146 | Sensory axonal neuropathy (HP:0003390) | 1.86219450 |
| 147 | Abnormal glucose tolerance (HP:0001952) | 1.85717565 |
| 148 | Torticollis (HP:0000473) | 1.85208244 |
| 149 | Mitral stenosis (HP:0001718) | 1.83945364 |
| 150 | Clumsiness (HP:0002312) | 1.82720444 |
| 151 | Lower limb asymmetry (HP:0100559) | 1.82416527 |
| 152 | Hypotension (HP:0002615) | 1.80937790 |
| 153 | Vascular tortuosity (HP:0004948) | 1.80779032 |
| 154 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79626175 |
| 155 | Nausea (HP:0002018) | 1.78265697 |
| 156 | Irritability (HP:0000737) | 1.78009031 |
| 157 | Status epilepticus (HP:0002133) | 1.77923568 |
| 158 | Esotropia (HP:0000565) | 1.77450571 |
| 159 | Bradykinesia (HP:0002067) | 1.76836376 |
| 160 | Focal dystonia (HP:0004373) | 1.75420478 |
| 161 | Broad metatarsal (HP:0001783) | 1.75120860 |
| 162 | Delayed epiphyseal ossification (HP:0002663) | 1.75093507 |
| 163 | Rickets (HP:0002748) | 1.74295228 |
| 164 | Subcapsular cataract (HP:0000523) | 1.73281543 |
| 165 | Hyperglycinuria (HP:0003108) | 1.73132729 |
| 166 | Urinary urgency (HP:0000012) | 1.72897735 |
| 167 | Widely spaced teeth (HP:0000687) | 1.72065578 |
| 168 | Prolonged partial thromboplastin time (HP:0003645) | 1.71016213 |
| 169 | Arterial tortuosity (HP:0005116) | 1.69165019 |
| 170 | Upper limb amyotrophy (HP:0009129) | 1.69124689 |
| 171 | Distal upper limb amyotrophy (HP:0007149) | 1.69124689 |
| 172 | Protuberant abdomen (HP:0001538) | 1.68880581 |
| 173 | Double outlet right ventricle (HP:0001719) | 1.67034250 |
| 174 | Congenital malformation of the right heart (HP:0011723) | 1.67034250 |
| 175 | Hypsarrhythmia (HP:0002521) | 1.65999274 |
| 176 | Hypokalemia (HP:0002900) | 1.65482236 |
| 177 | Abnormality of salivation (HP:0100755) | 1.63971490 |
| 178 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.63646084 |
| 179 | Abnormal auditory evoked potentials (HP:0006958) | 1.62491151 |
| 180 | Retinal dysplasia (HP:0007973) | 1.62322520 |
| 181 | Aortic dissection (HP:0002647) | 1.62271733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.66224177 |
| 2 | MST1R | 4.43294542 |
| 3 | ACVR1B | 3.81699786 |
| 4 | NTRK3 | 3.66057572 |
| 5 | TNIK | 3.55913518 |
| 6 | OXSR1 | 3.25806971 |
| 7 | MARK1 | 2.87942206 |
| 8 | CASK | 2.86911939 |
| 9 | RIPK1 | 2.84434009 |
| 10 | EPHA2 | 2.69961481 |
| 11 | MAP3K9 | 2.50608464 |
| 12 | FES | 2.48969643 |
| 13 | TYRO3 | 2.44957421 |
| 14 | WNK3 | 2.40199045 |
| 15 | MAP3K4 | 2.31224362 |
| 16 | STK39 | 2.27127070 |
| 17 | PRKG2 | 2.16084281 |
| 18 | WNK4 | 2.10853237 |
| 19 | PNCK | 2.07018042 |
| 20 | MET | 2.03649938 |
| 21 | LMTK2 | 2.03158279 |
| 22 | MAP3K12 | 1.99761660 |
| 23 | NEK1 | 1.99390677 |
| 24 | MINK1 | 1.98649762 |
| 25 | MAP2K7 | 1.98254188 |
| 26 | PDGFRA | 1.97196471 |
| 27 | AKT3 | 1.91626843 |
| 28 | ERN1 | 1.90208740 |
| 29 | EPHA3 | 1.84513725 |
| 30 | RIPK4 | 1.75774085 |
| 31 | PRPF4B | 1.70857481 |
| 32 | MAPK13 | 1.65822400 |
| 33 | DAPK2 | 1.49565104 |
| 34 | NTRK1 | 1.48553848 |
| 35 | NTRK2 | 1.46429547 |
| 36 | DDR2 | 1.43826827 |
| 37 | PAK6 | 1.35268526 |
| 38 | TESK1 | 1.33928056 |
| 39 | PLK2 | 1.29420899 |
| 40 | PRKCG | 1.28755124 |
| 41 | CDK5 | 1.27138942 |
| 42 | FGFR4 | 1.23318052 |
| 43 | MYLK | 1.23241206 |
| 44 | MAP2K4 | 1.23142032 |
| 45 | NME1 | 1.21883057 |
| 46 | KSR2 | 1.19902254 |
| 47 | PIK3CA | 1.17130839 |
| 48 | SGK223 | 1.13680130 |
| 49 | SGK494 | 1.13680130 |
| 50 | STK38 | 1.12979053 |
| 51 | EPHB2 | 1.11663890 |
| 52 | CDK19 | 1.11418309 |
| 53 | GRK5 | 1.08287785 |
| 54 | DAPK1 | 1.05900512 |
| 55 | CAMKK1 | 1.03690699 |
| 56 | CAMK2A | 1.02520511 |
| 57 | CAMK2B | 1.01553810 |
| 58 | ARAF | 0.97745116 |
| 59 | PINK1 | 0.95954721 |
| 60 | NEK6 | 0.95413137 |
| 61 | LATS1 | 0.94673528 |
| 62 | KSR1 | 0.93914841 |
| 63 | PDK2 | 0.93833532 |
| 64 | PTK2 | 0.93768667 |
| 65 | MAP3K2 | 0.91955697 |
| 66 | CAMKK2 | 0.89184849 |
| 67 | PKN1 | 0.89011918 |
| 68 | IRAK2 | 0.87361058 |
| 69 | PTK2B | 0.86484876 |
| 70 | SIK1 | 0.86154947 |
| 71 | PAK3 | 0.85552376 |
| 72 | STK38L | 0.84522860 |
| 73 | FGR | 0.84432748 |
| 74 | BMPR2 | 0.80381916 |
| 75 | MAP3K10 | 0.78808355 |
| 76 | UHMK1 | 0.75866402 |
| 77 | PRKD3 | 0.74641513 |
| 78 | SGK1 | 0.72153733 |
| 79 | MAP3K13 | 0.70822875 |
| 80 | ERBB3 | 0.69850411 |
| 81 | PRKCE | 0.68014279 |
| 82 | JAK1 | 0.65680109 |
| 83 | STK11 | 0.65471772 |
| 84 | PDPK1 | 0.65009006 |
| 85 | PRKACG | 0.63887926 |
| 86 | EPHB1 | 0.63498618 |
| 87 | CDK14 | 0.62022902 |
| 88 | ERBB2 | 0.61616388 |
| 89 | BCR | 0.61478302 |
| 90 | TSSK6 | 0.61459307 |
| 91 | PDK4 | 0.61011966 |
| 92 | PDK3 | 0.61011966 |
| 93 | CSNK1G2 | 0.59823871 |
| 94 | PDGFRB | 0.59622143 |
| 95 | TIE1 | 0.58790605 |
| 96 | SGK2 | 0.56892708 |
| 97 | CAMK1 | 0.55540049 |
| 98 | MARK2 | 0.55032040 |
| 99 | CAMK2D | 0.54787095 |
| 100 | CSNK1A1L | 0.54749654 |
| 101 | DYRK1A | 0.54530178 |
| 102 | CDK18 | 0.54349392 |
| 103 | CDK15 | 0.53441430 |
| 104 | SIK2 | 0.53415117 |
| 105 | PDK1 | 0.52784737 |
| 106 | FER | 0.51976452 |
| 107 | PHKG2 | 0.51210366 |
| 108 | PHKG1 | 0.51210366 |
| 109 | MAPKAPK5 | 0.51062969 |
| 110 | SRC | 0.49782013 |
| 111 | DAPK3 | 0.48143524 |
| 112 | RPS6KA2 | 0.47457505 |
| 113 | ROCK2 | 0.46026015 |
| 114 | RET | 0.45134391 |
| 115 | FYN | 0.44499951 |
| 116 | CDK11A | 0.44301818 |
| 117 | CSNK1G1 | 0.43680975 |
| 118 | PRKCZ | 0.43600292 |
| 119 | LIMK1 | 0.42824223 |
| 120 | CAMK2G | 0.42368284 |
| 121 | CDC42BPA | 0.42174203 |
| 122 | CSNK1G3 | 0.41254943 |
| 123 | NEK9 | 0.40592330 |
| 124 | CSNK1A1 | 0.39219703 |
| 125 | GRK7 | 0.39115455 |
| 126 | PRKACA | 0.38890105 |
| 127 | LATS2 | 0.38560935 |
| 128 | ERBB4 | 0.37980409 |
| 129 | RPS6KA3 | 0.37644110 |
| 130 | GRK1 | 0.36527421 |
| 131 | WNK1 | 0.35959633 |
| 132 | CAMK4 | 0.35904065 |
| 133 | PRKCH | 0.35050044 |
| 134 | RAF1 | 0.34369257 |
| 135 | PRKCA | 0.33702222 |
| 136 | ROCK1 | 0.33537131 |
| 137 | MAP2K1 | 0.31834599 |
| 138 | SGK3 | 0.31537484 |
| 139 | PRKCQ | 0.31204398 |
| 140 | TAOK1 | 0.30730467 |
| 141 | ICK | 0.29756868 |
| 142 | CSNK1E | 0.29122781 |
| 143 | CCNB1 | 0.25652222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.86512203 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08941749 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.08719193 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.00366008 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.78085327 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.78031334 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.70927643 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.58668782 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.54240600 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50988323 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46930916 |
| 12 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42114130 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.41983148 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36875567 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.34181774 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.26253299 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23449864 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.20785660 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19658203 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 2.19635862 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15755248 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 2.13807004 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.12163386 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.10835355 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.97055497 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.96957315 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96390598 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94552687 |
| 29 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.91128778 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85697830 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84566514 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.79140366 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73984721 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.70155804 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66102283 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64880009 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64775296 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61467011 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58586119 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56241807 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54249501 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.52581070 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.48833569 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.48622829 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.47070093 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.43696216 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42814574 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41663645 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38494755 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36296296 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33521197 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33083852 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32086423 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29613943 |
| 55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27671222 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26808584 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26453995 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25481733 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25284491 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23288062 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 1.21258784 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20622580 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18598458 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14941409 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09918198 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 1.09660053 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09508351 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09282246 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08162951 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07074259 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06857076 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05431483 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00428437 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99797754 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.96285794 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.96083046 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95540290 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95342530 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94919371 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94878194 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94214668 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89787626 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87425686 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86919345 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83161573 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82304964 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82200010 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81562164 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80571461 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.80236597 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78989560 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78944037 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.78930366 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78664977 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77304041 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70698002 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70404831 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69997267 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67228865 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.66105563 |
| 101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65465022 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65163955 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63806239 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.63698214 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61424545 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61211158 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60611986 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60365360 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60294286 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58570165 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.53962687 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52397668 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52355407 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50486453 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48458858 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47649510 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47090698 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46052340 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45793358 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44908762 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.44546818 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44455989 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44448369 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43764993 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41660428 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.41273302 |
| 127 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39194205 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36729314 |
| 129 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34745146 |
| 130 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34656388 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34550064 |
| 132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34267969 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34031625 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33692177 |
| 135 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33020288 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32158833 |
| 137 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31832403 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31637112 |
| 139 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31522888 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30741245 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30635650 |
| 142 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30184552 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29011426 |
| 144 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28324509 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25644477 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25593406 |
| 147 | Endocytosis_Homo sapiens_hsa04144 | 0.25380749 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25281908 |
| 149 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24951596 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.24462050 |
| 151 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.19442737 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.18097060 |

